Industry Research Reports Data

The north america thermoplastic polyolefin market is projected to reach USD 704.24 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period 2024-2030. The growth of the market is majorly driven by growing awareness of sustainable materials and advancements in processing technologies. Thermoplastic polyolefin is a multipurpose material that is well-known for its flexibility, toughness, and ability to withstand abrasion and oil. It is frequently used for applications like flexible hoses, seals, and protective casings in a variety of industries, including electronics, footwear, and the automotive sector. TPU is a sustainable material for manufacturing operations since it is simple to form and recycle. View Full Report:   https://www.precisionbusinessinsights.com/market-reports/north-america-thermoplastic-polyolefin-market The north america thermoplastic polyolefin market segmentation: 1) By Application: Automotive, Buildings & Constructio

The report " Polyphenylene Sulfide Market   By Type (Cross-linked PPS and Linear PPS), By Application (Automotive, Filter Bags, Aerospace, Electrical & Electronics, Coatings, Industrial and Other Applications) - Global Forecasts to 2030" The global polyphenylene sulfide market is projected to reach USD 1.54 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period 2024-2030. The growth of the  market  is majorly driven by the rising requirement for lightweight and fuel-efficient vehicles. Request sample report at   https://www.precisionbusinessinsights.com/request-sample/?product_id=37030    Competitive Dashboard: The prominent key players operating in the global polyphenylene sulfide market are  Solvay SA, Tosoh Corporation, DIC Corporation, Toray Industries Inc., Kureha Corporation, Fortron Industries LLC Regional Overview: The report also examines the current concerns and their Future Effects on the  Polyphenylene Sulfide M

The report " Oncology Biosimilars Market   By Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others) By Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, and Others) - Global Forecasts to 2030" The global oncology biosimilars market is projected to reach USD 3.5 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 29.0% during the forecast period 2024-2030. The growth of the  market  is majorly driven by the  increase in the number of research and development activities and technological advancement Request sample report at   https://www.precisionbusinessinsights.com/request-sample/?product_id=19301 Competitive Dashboard: The prominent key players operating in the global oncology biosimilars market are  Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland)

The report " Cardiovascular Drugs Market   By Disease Type (Hypertension, Congestive Heart disease, Angina pectoris, Myocardial Ischemia, Peripheral Artery Diseases, Atherosclerosis, Cardiomyopathy, Others), By Drug Class (Anti-hypertensive Drugs, Lipid lowering drugs, Beta-adrenergic Blocking Agents, Vasodilators, Anti-platelet Agents, Others), By Route of Administration (Oral, Buccal/sublingual, Intravenous, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Forecasts to 2030" The global cardiovascular drugs market is projected to reach USD 146.51 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing r&d investments in efficient drug development. Request sample report at   https://www.precisionbusinessinsights.com/request-sample/?product_id=19277 Competitive Dashboard: The prominent key players operatin

The report " Esoteric Testing Market   By Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology testing, Immunology Testing, Neurology Testing, and Other), By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Real-Time Polymerase Chain Reaction, DNA Sequencing, Flow Cytometry,  and Others), By End User (Hospital-based Laboratories, Independent and Reference Laboratories) - Global Forecasts to 2030" The global esoteric testing market is projected to reach USD 26,397.4 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period 2024-2030. The growth of the  market  is majorly driven by the integration of artificial intelligence (ai) and big data and the rising demand for personalized medicine Request sample report at   https://www.precisionbusinessinsights.com/request-sample/?product_id=60293    Competitive Dashboard: The prominent key play

The report " Malaria Testing Market   By Product (Instruments and Kits and Reagents and Consumables), By Type (Lab-based Test and Point of Care Test), By Technique (Polymerase Chain Reaction, Immunochromatography, Fluorescent In-situ Hybridization, DNA Microarrays, and Others), By End Users (Hospitals and Clinics, Diagnostic Centres, and Others) - Global Forecasts to 2030" The global malaria testing market is projected to reach USD 833.2 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing technological advancements and efficient diagnostics and scale-up of rapid diagnostic tests and universal access to diagnosis Request sample report at   https://www.precisionbusinessinsights.com/request-sample/?product_id=546091 Competitive Dashboard: The prominent key players operating in the global malaria testing market are Abbott Laboratories, Access Bio, Beckman Co